Aspergillus flavus keratitis in Adana, Turkey Macit Ilkit, MD Division of Mycology, Department of Microbiology, Faculty of Medicine, University of Çukurova, Adana, Turkey
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Slayt 1Macit Ilkit, MD
Faculty of Medicine, University of Çukurova, Adana, Turkey
Nijmegen, June 2014
• Three clinical forms:
(iii) orbital infections
• Keratitis, an infection of the cornea, may result in reduced
vision or blindness
• Mainly in farmers and agriculture-based tropical countries
(India, the Middle-East, North Africa)
Thomas and Kaliamurthy, 2013
• 16.5%- co-existing disease
• Over 1 million eyes go blind each year because of MK
Manikandan et al, 2013; www.gaffi.org
Filamentous MK-Causative fungi
• Environmentally widespread molds
• The genera of Aspergillus, Fusarium, Curvularia, Scedosporium,
and Paecilomyces
• A. flavus (section Flavi) is one of the most common
pathogen!
Thomas and Kaliamurthy, 2013; Manikandan et al, 2013
Background-Risk factors
• Ocular trauma, caused by vegetative material (soil, leaves, or
tree branches)
• History of contact-lens wearing
• Widespread use of broad-spectrum antibiotics/steroids,
prolonged
• The most common surgery worldwide is cataract surgery: but MK is
less reported
Thomas and Kaliamurthy, 2013; Kredics et al, 2015
Background-Treatment
(iii) therapy-refractive nature
(iv) poor corneal penetration of medications
(v) limited availability/efficacy of available drugs
Thomas and Kaliamurthy, 2013; Manikandan et al, 2013; Kredics et
al, 2015; www.gaffi.org
MK-Intractable problem
• Corneal collagen cross-linking
• Topical steroids along with antifungals (polyenes or triazoles)
are commonly applied for treatment of MK.
Thomas and Kaliamurthy, 2013; Manikandan et al, 2013; Kredics et
al, 2015; Erdem et al. (In preparation)
Drug of choice
• Natamycine (5% suspension; pimaricine) and AmB are the drug of
choices in filamentous MK
• But not active against A. flavus keratitis!!
• New strategies are needed!
• Antifungal therapy for MK is 60-75% effective in saving
sight
Oz et al, 2012;2016; Thomas and Kaliamurthy, 2013; Kredics et al,
2015
Aim
Çukurova University, Adana, Turkey
• 64 corneal scrapings/smears; corneal ulcer (7 cases)
• Culture-positive (6 cases, %)
• Fusarium spp.-2 cases
• The time between the clinical presentation and diagnosis by
culture was 2 weeks (8-25 days)
Predisposing factors
History: Age, 23-56 years
No history of systemic comorbidities
Corneal ulcer
• ulcer with satellite lesions (2 cases)
• Ocular pain, photophobia, mild disturbance of visual acuity-left
eye-5 d
• History: wearing soft contact lenses-5 years
• Ruled out use: (i) sleeping with lenses
(ii) using tap water to clean
• 20/400-left eye, irregular margin
• switch therapy: topical voriconazole (hourly) + systemic
ketoconazole (twice a day)
• day 18: corneal collagen crosslinking with UV- A and riboflavin +
intrastromal voriconazole
Case 1
• topical propamidine isethionate (Brolene 0.1% eye drop) and
chlorhexidine
• 3-month: complete recovery
Case 2
• 28-year-old man
• redness, pain, and a white fleck in his left-eye for 20 d
• mild, but resistant, keratitis
• worker at an iron-steel factory, ocular trauma of splashed iron
dust
• history of topical antibiotics, not resolved
• slit-lamp: well-defined corneal ulcer
• culture: A. flavus
• rapid response:
Case 3
• 56-year-old woman
• ocular trauma inflicted by an umbrella tip to the right eye
1-month previously
• pain, redness, low visual acuity (hand motion level)
• slit-lamp exam: corneal ulcer, satellite lesions, and
hypopyon
Case 3
• clinical signs progressed; culture- A. flavus
• day 12: switch intrastromal voriconazole injection
• no controlled of infection
• day 24: penetrating keratoplasty
• 6-months follow-up: no infection recurred
• visual acuity: 20/200
• penetrating keratoplasty-left eye-2-years previously
• mixed bacterial + fungal infection?
• visual acuity: hand-motion level, corneal edema, infiltrate size
increase, hypopyon
• empirical therapy: voriconazole (10 mg/ml) drop hourly
initiated+vancomycin+amikacin (6 drops/day)
• Fungal culture: A. flavus
• corneal collagen crosslinking (using uv and riboflavin).
• day 10: 20/400
30°C 7 d
37°C 3 d
Fig. 2 Microscopic examination of a corneal scraping sample. Black
arrows indicate fungal hyphae (Papanicolaou dye)
Phylogeny, taxonomy, and nomenclature
• The β-tubulin gene, calmodulin, and, a lesser degree, ITS
• A. flavus, A. oryzae, A. tamarii, A. nomius..
Tam et al, 2012 Gonçalves et al, 2013
AFST-EUCAST
Discussion
• We observed that A. flavus keratitis can be present with
different underlying factors and clinical conditions.
• This study suggested that A. flavus keratitis may occur with a
high prevalence (66.7%) in a subtropical climate in Adana,
Turkey
Corneal collagen cross-linking
• MK patients which were poor/no responder to topical voriconazole
treatment
• Adjunctive therapy using ‘CXL for the management of mycotic
keratitis’ (In preparation)
• CXL treatment may be effective in patients with small and
superficial mycotic ulcers
Corneal collagen cross-linking (CXL)
Discussion
• A. fumigatus (n=23, 11.5%)
Manikandan et al, 2013
• We recently tested 50 ocular fungal isolates, including three CBS
A. flavus isolates;
Proteinase: 30%
Phospholipase: 42%
• Eye clinics-research laboratory
Thomas and Kaliamurthy, 2013; Kredics et al, 2015;
Treatment of MK
• Aspergillus spp. keratitis- that show resistance to topical
natamycine and AMB
• Voriconazole- drug of choice
Is mycology lab. indeed important?
• Region-specific epidemiological details are important for prompt
treatment and prevention;
(i) ophthalmologists
Kredics et al, 2015; www.gaffi.org Erdem et al, In press
Conclusion
• A combination of antifungal therapy and supportive surgical
intervention may resolve infection caused by A. flavus in the
cornea
• Our results warrants the role of early diagnosis and initiation
of specific antifungal therapy to improve outcome
Acknowledgments